Collier EditionCOVID-19

Orchidia Medical Group Offers a Cutting-Edge Peptide that Is Proving to Boost Immunity

By Dr. Carolina Young Ortiz

Orchidia Medical GroupThymosin Alpha-1 (Ta1) has been known as an excellent immune modulator. Thymosin is a small protein produced naturally by the thymus gland which stimulates the development of disease-fighting T cells. The thymus is an integral part of your immune system, where individual T-cells are made to respond to the millions of bacteria, fungi, or viruses that could invade your body.

Commonly prescribed for the treatment for chronic viral diseases, Thymosin Alpha-1 has also been shown to increase innate immunity factors and help fight against harmful autoimmune processes. It is given to help control inflammation associated with chronic diseases, which can cause excess fatigue.

Ta1 Benefits May Include
• Modulates immune function and inflammation
• Improved chronic fatigue
• Suppresses tumor growth
• Improved autoimmune function
• Anti-fungal, anti-viral and anti-bacterial properties
• Protects against oxidative damage
• Increases vaccine effectiveness
• Helps eliminate unhealthy cells and stop infection or cancer growth

Study on Thymosin Alpha1 and Patients with COVID-19
According to a recent 2020 COVID-19 study utilizing Thymosin Alpha 1, the following information, directly corelates to the findings on Ta1 and its function in fighting the novel coronavirus.

We previously reported that lymphocytopenia and T cell exhaustion is notable in acute COVID19 patients, especially in aged and severe cases. Thymosin alpha 1 (Tα1) had been used in the treatment of viral infections as an immune response modifier for many years… We retrospectively reviewed the clinical outcomes of 76 severe cases with COVID-19 admitted into two hospitals in Wuhan from December 2019 to March 2020. The thymus output in peripheral blood mononuclear cells (PBMCs) from COVID-19 patients was measured by T cell receptor excision circles (TREC). The levels of T cell exhaustion markers PD-1 and Tim-3 on CD8+ T cells were detected by flow cytometry.1

Tα1 supplement significantly reduce mortality of severe COVID-19 patients. COVID-19 patients with the counts of CD8+ T cells or CD4+ T cells in circulation lower than 400/μL or 650/μL, respectively, gain more benefits from Tα1. Tα1 reverses T cell exhaustion and recovers immune reconstitution through promoting thymus output during SARS-CoV-2 infection.1

STEPS to Strengthen your Immune System with Peptide, Thymosin A1
1. Schedule a virtual consultation online with our physicians.

2. No trip to the doctor’s office required. With medical providers who come to you and virtual access to our doctors.

3. We deliver all treatments directly to you with express shipping. No inconvenient trips to the pharmacy

Ochidia Medical Group can check your levels in-house, so there is no longer a need to wait.

Orchidia Medical Group
Our mission is to utilize the latest in medical science and apply this with the simple understanding that you want to look, feel, and live better. Let us help you realize your potential well-being and become the individual that you have long desired. Your well-being is worth it!

Call us today at 239-330-9855 or visit us online at orchidiamedicalgroup.com.

Orchidia Medical Group
2590 Golden Gate Parkway, Suite 104
Naples FL 34105
Space is Limited
RSVP 239-333-8809

Reference:
Yueping Liu Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells, 2020, Published by Oxford University Press for the Infectious Diseases Society of America, https://pubmed.ncbi.nlm.nih.gov/32442287/
DOI: 10.1093/cid/ciaa630

Related Articles

Back to top button
Close